GR3018970T3 - Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions. - Google Patents

Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions.

Info

Publication number
GR3018970T3
GR3018970T3 GR960400371T GR960400371T GR3018970T3 GR 3018970 T3 GR3018970 T3 GR 3018970T3 GR 960400371 T GR960400371 T GR 960400371T GR 960400371 T GR960400371 T GR 960400371T GR 3018970 T3 GR3018970 T3 GR 3018970T3
Authority
GR
Greece
Prior art keywords
freeze
polymer dispersions
pharmaceutical compositions
dried polymer
release pharmaceutical
Prior art date
Application number
GR960400371T
Other languages
English (en)
Inventor
Dev K Mehra
Chimanal I Patel
Clayton I Bridges
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of GR3018970T3 publication Critical patent/GR3018970T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR960400371T 1989-03-23 1996-02-14 Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions. GR3018970T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32793489A 1989-03-23 1989-03-23

Publications (1)

Publication Number Publication Date
GR3018970T3 true GR3018970T3 (en) 1996-05-31

Family

ID=23278720

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960400371T GR3018970T3 (en) 1989-03-23 1996-02-14 Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions.

Country Status (8)

Country Link
US (1) US5326572A (el)
EP (1) EP0388954B1 (el)
AT (1) ATE130511T1 (el)
CA (1) CA2012853A1 (el)
DE (1) DE69023682T2 (el)
DK (1) DK0388954T3 (el)
ES (1) ES2079389T3 (el)
GR (1) GR3018970T3 (el)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968551A (en) 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
SE9203594D0 (sv) * 1992-11-30 1992-11-30 Christer Nystroem Laekemedel i dispersa system
DE4244466C2 (de) * 1992-12-24 1995-02-23 Pharmatech Gmbh Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und deren Verwendung zur Herstellung von pharmazeutischen Präparaten
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
DE4324474A1 (de) * 1993-07-21 1995-01-26 Henkel Kgaa Verwendung ausgewählter Polyvinylacetat-Dispersionen für die Oberflächenverfestigung von Sand und/oder Erdreich
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
DE4413350A1 (de) * 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
US5684121A (en) * 1994-12-06 1997-11-04 Isp Investments Inc. N-vinyl lactam polymer containing tablets of low friability and high rate of dissolution
ES2210321T3 (es) * 1994-12-19 2004-07-01 Daiichi Pharmaceutical Co., Ltd. Preparacion granular de liberacion prolongada y procedimiento de produccion.
US6165493A (en) * 1997-10-22 2000-12-26 New York Blood Center, Inc. "Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
US5985313A (en) * 1997-10-22 1999-11-16 New York Blood Center, Inc. Method for decreasing the frequency of transmission of viral infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
MXPA02004293A (es) 1999-10-29 2002-10-31 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada..
EP1337244A4 (en) 2000-10-30 2006-01-11 Euro Celtique Sa HYDROCODON FORMULATIONS WITH CONTROLLED RELEASE
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
US20040115266A1 (en) * 2002-02-01 2004-06-17 Namburi Ranga Raju Oral itraconazole formulations and methods of making the same
WO2005000237A2 (en) * 2003-06-25 2005-01-06 University Of Tennessee Research Foundation Granules containing biologically active substances
JP2009526096A (ja) * 2006-02-07 2009-07-16 エフ エム シー コーポレーション 徐放性被覆をつくるためのコーティング方法
US20070281016A1 (en) * 2006-06-06 2007-12-06 Endo Pharmaceuticals Inc., A Delaware Corporation Sustained release oxycodone composition with acrylic polymer and surfactant
AU2007275034A1 (en) * 2006-07-21 2008-01-24 Lab International Srl Hydrophilic abuse deterrent delivery system
US9555167B2 (en) * 2006-12-11 2017-01-31 3M Innovative Properties Company Biocompatible antimicrobial compositions
US20080200890A1 (en) * 2006-12-11 2008-08-21 3M Innovative Properties Company Antimicrobial disposable absorbent articles
CA3110272A1 (en) * 2018-08-31 2020-03-05 Evonik Operations Gmbh Process for preparing a polymer powder
CN114456404B (zh) * 2022-01-24 2024-02-13 哈尔滨工业大学 一种液态金属柔性可穿戴器件及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800463A (en) * 1953-05-14 1957-07-23 Shawinigan Resins Corp Polyvinyl acetate powder and process of making the same
US2809192A (en) * 1954-05-25 1957-10-08 Atlantic Res Corp Method of making cellulose esters in the form of small, dense, spherical particles
US3942261A (en) * 1973-12-21 1976-03-09 Toyo Ink Manufacturing Co., Ltd. Method for producing powder paint
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
AU569277B2 (en) * 1983-03-03 1988-01-28 Dow Chemical Company, The Aqueuos dispersion of water-insoluble organophilic cellulose ether for sustained release of active agents
US4652442A (en) * 1983-07-05 1987-03-24 Arcana Chem. Pharm. Fabrik Gesellschaft M.B.H. Process of producing a sustained release preparation containing indomethacin or niomethacin
ATE84806T1 (de) * 1987-04-16 1993-02-15 Christian Bindschaedler Verfahren zur herstellung eines wasserunloeslichen polymerpulvers, das in einer fluessigen phase redispergiert werden kann und verfahren zur herstellung einer dispersion des polymerpulvers.
US4960814A (en) * 1988-06-13 1990-10-02 Eastman Kodak Company Water-dispersible polymeric compositions

Also Published As

Publication number Publication date
CA2012853A1 (en) 1990-09-23
DE69023682D1 (de) 1996-01-04
DE69023682T2 (de) 1996-04-18
EP0388954A2 (en) 1990-09-26
EP0388954B1 (en) 1995-11-22
ES2079389T3 (es) 1996-01-16
EP0388954A3 (en) 1992-09-09
ATE130511T1 (de) 1995-12-15
DK0388954T3 (da) 1995-12-18
US5326572A (en) 1994-07-05

Similar Documents

Publication Publication Date Title
GR3018970T3 (en) Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions.
US5044091B1 (en) Method of preparing a freeze-dried formulation of a drug
WO2002101412A3 (en) Spray freeze-dried compositions
CA2058835A1 (en) Stable pharmaceutical composition and method for its production
BG101781A (en) Active substance-containing solid preparation
BR9808933A (pt) Composição sob forma de microcápsulas ou de implantes, processo de preparação de uma substância hidrossolúvel, substância ativa, acetato de triptorelina, acetato de lanreotìdeo, ou acetato de octreotìdeo, e rna de filamento duplo
HUT75247A (en) Solid pharmaceutical composition comprising an excipient capable of binding water and process for its production
ZA973792B (en) Polymer powders redispersible in aqueous solution
PT82575A (fr) Procede de preparation d'un produit conjugue constitue d'une adhesine de s.mutans de nature proteique d'une composition a activite immunogene et d'un polysaccharide de s.mutans et son utilisation notamment dans des vaccins anti-caries
DE59305700D1 (de) Verfahren zur Herstellung von festen pharmazeutischen Retardformen
NO172423C (no) Fremgangsmaate for fremstilling av et brusende farmasoeytisk pulver- eller tablettpreparat inneholdende ibuprofen
ZA892399B (en) Pharmaceutical compositions of piroxicam in aqueous solution and process for their preparation
ATE40647T1 (de) Extraktionsverfahren von propolis, danach erhaltenes wasserloesliches getrocknetes pulver aus propolis, propolisenthaltende kosmetische und pharmazeutische praeparate.
ATE177944T1 (de) Pellets
EP0009609A3 (en) Adjuvant for promoting absorption of therapeutically active substances through the digestive tract, pharmaceutical composition comprising said adjuvant and process for preparing said pharmaceutical composition; enamine derivatives
FR2613223B1 (fr) Forme galenique se presentant sous la forme de grains hydrosolubles, en particulier a base d'un extrait sec de ginkgo biloba, et son procede de preparation
ES2111149T3 (es) Extracto a base de proteinas bacterianas, procedimiento para su preparacion y composicion farmaceutica que lo contiene.
DE59001005D1 (de) Hilfsmittelfreie riboflavingranulate.
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
EP0385909A3 (en) A kit or composition for the prevention or treatment of HIV-1 infections
PL261696A1 (en) Method of simultaneously evaporating and granulating extracted substances from calf's blood
DE59310192D1 (de) Ligninpolymerzusammensetzung zur Behandlung von Hautproblemen
ES2084747T3 (es) Polimeros en emulsion liberados de emulsionantes en preparados farmaceuticos con liberacion retardada de la sustancia activa, y su preparacion.
FR2657010B1 (fr) Composition pharmaceutique sous forme de suspension aqueuse stable a base de sucrafalte et d'une substance anti-acide ainsi que son procede de preparation.
DK45592A (da) Poly(lactid-co-glycolid)polymer omfattende mindst 25 mol% maelkesyreenheder og op til 75 mol% glycosyreenheder samt fremgangsmaade til fremstilling heraf